143 related articles for article (PubMed ID: 8437849)
1. Different structural organization of Ras and Rho effector domains.
Self AJ; Paterson HF; Hall A
Oncogene; 1993 Mar; 8(3):655-61. PubMed ID: 8437849
[TBL] [Abstract][Full Text] [Related]
2. Effector domain mutants of Rho dissociate cytoskeletal changes from nuclear signaling and cellular transformation.
Zohar M; Teramoto H; Katz BZ; Yamada KM; Gutkind JS
Oncogene; 1998 Aug; 17(8):991-8. PubMed ID: 9747878
[TBL] [Abstract][Full Text] [Related]
3. Cellular functions of TC10, a Rho family GTPase: regulation of morphology, signal transduction and cell growth.
Murphy GA; Solski PA; Jillian SA; Pérez de la Ossa P; D'Eustachio P; Der CJ; Rush MG
Oncogene; 1999 Jul; 18(26):3831-45. PubMed ID: 10445846
[TBL] [Abstract][Full Text] [Related]
4. Possible involvement of the inactivation of the Rho-Rho-kinase pathway in oncogenic Ras-induced transformation.
Izawa I; Amano M; Chihara K; Yamamoto T; Kaibuchi K
Oncogene; 1998 Dec; 17(22):2863-71. PubMed ID: 9879992
[TBL] [Abstract][Full Text] [Related]
5. Ras-interacting domain of Ral GDP dissociation stimulator like (RGL) reverses v-Ras-induced transformation and Raf-1 activation in NIH3T3 cells.
Okazaki M; Kishida S; Murai H; Hinoi T; Kikuchi A
Cancer Res; 1996 May; 56(10):2387-92. PubMed ID: 8625316
[TBL] [Abstract][Full Text] [Related]
6. The non-catalytic domain of ras-GAP inhibits transformation induced by G protein coupled receptors.
Xu N; McCormick F; Gutkind JS
Oncogene; 1994 Feb; 9(2):597-601. PubMed ID: 8290270
[TBL] [Abstract][Full Text] [Related]
7. A glutamic acid residue at position 31 of Ras protein is essential to the signal transduction for neurite outgrowth of PC12 cells and the stimulation of GTPase activity by GAPRas.
Shirouzu M; Fujita-Yoshigaki J; Ito Y; Koide H; Nishimura S; Yokoyama S
Oncogene; 1992 Mar; 7(3):475-80. PubMed ID: 1549361
[TBL] [Abstract][Full Text] [Related]
8. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
[TBL] [Abstract][Full Text] [Related]
9. Rho small G protein and cytoskeletal control.
Takai Y; Kaibuchi K; Sasaki T; Tanaka K; Shirataki H; Nakanishi H
Princess Takamatsu Symp; 1994; 24():338-50. PubMed ID: 8983086
[TBL] [Abstract][Full Text] [Related]
10. R-ras interacts with rasGAP, neurofibromin and c-raf but does not regulate cell growth or differentiation.
Rey I; Taylor-Harris P; van Erp H; Hall A
Oncogene; 1994 Mar; 9(3):685-92. PubMed ID: 8108110
[TBL] [Abstract][Full Text] [Related]
11. A peptide from the GAP-binding domain of the ras-p21 protein and azatyrosine block ras-induced maturation of Xenopus oocytes.
Chung DL; Brandt-Rauf P; Murphy RB; Nishimura S; Yamaizumi Z; Weinstein IB; Pincus MR
Anticancer Res; 1991; 11(4):1373-8. PubMed ID: 1746893
[TBL] [Abstract][Full Text] [Related]
12. Linear free energy relationships in the intrinsic and GTPase activating protein-stimulated guanosine 5'-triphosphate hydrolysis of p21ras.
Schweins T; Geyer M; Kalbitzer HR; Wittinghofer A; Warshel A
Biochemistry; 1996 Nov; 35(45):14225-31. PubMed ID: 8916907
[TBL] [Abstract][Full Text] [Related]
13. Ras-GTPase activating protein inhibition specifically induces apoptosis of tumour cells.
Leblanc V; Delumeau I; Tocqué B
Oncogene; 1999 Aug; 18(34):4884-9. PubMed ID: 10490822
[TBL] [Abstract][Full Text] [Related]
14. Suppression of c-ras transformation by GTPase-activating protein.
Zhang K; DeClue JE; Vass WC; Papageorge AG; McCormick F; Lowy DR
Nature; 1990 Aug; 346(6286):754-6. PubMed ID: 2201922
[TBL] [Abstract][Full Text] [Related]
15. Ras regulatory interactions: novel targets for anti-cancer intervention?
Prendergast GC; Gibbs JB
Bioessays; 1994 Mar; 16(3):187-91. PubMed ID: 8166672
[TBL] [Abstract][Full Text] [Related]
16. Critical role of Rho in cell transformation by oncogenic Ras.
Prendergast GC; Khosravi-Far R; Solski PA; Kurzawa H; Lebowitz PF; Der CJ
Oncogene; 1995 Jun; 10(12):2289-96. PubMed ID: 7784077
[TBL] [Abstract][Full Text] [Related]
17. ras effector loop mutations that dissociate p120GAP and neurofibromin interactions.
Stang S; Bottorff D; Stone JC
Mol Carcinog; 1996 Jan; 15(1):64-9. PubMed ID: 8561868
[TBL] [Abstract][Full Text] [Related]
18. Signal transduction elements of TC21, an oncogenic member of the R-Ras subfamily of GTP-binding proteins.
Movilla N; Crespo P; Bustelo XR
Oncogene; 1999 Oct; 18(43):5860-9. PubMed ID: 10557073
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic activity of Tiam1 and Rac1 in NIH3T3 cells.
van Leeuwen FN; van der Kammen RA; Habets GG; Collard JG
Oncogene; 1995 Dec; 11(11):2215-21. PubMed ID: 8570171
[TBL] [Abstract][Full Text] [Related]
20. Identification of amino acids in p21ras involved in exchange factor interaction.
Howe LR; Marshall CJ
Oncogene; 1993 Sep; 8(9):2583-90. PubMed ID: 8361768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
